C-Pharm
C-Pharm, a leading name in the pharmaceutical industry, is headquartered in HR and operates extensively across various regions. Founded in [year], the company has established itself as a key player in the development and distribution of innovative healthcare solutions. C-Pharm focuses on a diverse range of products, including prescription medications and over-the-counter treatments, distinguished by their commitment to quality and efficacy. With a strong emphasis on research and development, C-Pharm has achieved significant milestones, enhancing its market position through strategic partnerships and cutting-edge technology. The company is recognised for its unique formulations that address unmet medical needs, solidifying its reputation as a trusted provider in the healthcare sector. C-Pharm continues to drive advancements in pharmaceuticals, contributing to improved patient outcomes globally.
DitchCarbon Score
How does C-Pharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
C-Pharm's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
C-Pharm's reported carbon emissions
C-Pharm, headquartered in HR, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data, it is essential to note that C-Pharm is likely aware of the growing importance of sustainability and climate action within the pharmaceutical industry. Companies in this sector are increasingly focusing on reducing their carbon footprints and implementing environmentally responsible practices. C-Pharm may be exploring opportunities to enhance its climate commitments in line with industry standards, although specific initiatives or targets have not been disclosed at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
C-Pharm is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
